- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Hologic settles dispute with Fleet
Hologic has reached a settlement in its two-year dispute with Fleet Business Credit regarding a Master Product Financing Agreement entered into in September 1996. Under the original agreement, Fleet acquired Hologic bone densitometry systems to lease to
Hologic has reached a settlement in its two-year dispute with Fleet Business Credit regarding a Master Product Financing Agreement entered into in September 1996. Under the original agreement, Fleet acquired Hologic bone densitometry systems to lease to physicians on a fee-per-scan basis throughout the U.S. During the course of this three-year deal, Hologic sold around $61 million of bone densitometers. Fleet, however, suffered substantial losses under the program and sought to shift losses to Hologic. The settlement agreement provides for all claims to be dismissed with prejudice, and for Hologic to repay Fleet $3.05 million: $1.5 million cash and a note for $1.55 million payable in three years. Certain fees collected from Fleet customers, including scan overages and excess pool deposits, will be counted against the money Hologic must repay Fleet. This credit could reduce the total due to Fleet in three years from $3.05 million to about $1 million.
FDA Approves Fluorescence Imaging System for Detecting Residual Breast Cancer
April 18th 2024The combination of the optical imaging agent Lumisight and the fluorescence imaging device Lumicell Direct Visualization System, collectively known as LumiSystem, reportedly offers 84 percent accuracy with real-time detection of residual breast cancer after lumpectomy procedures.
Study of Ofatumumab for Multiple Sclerosis Shows 'Profoundly Suppressed MRI Lesion Activity'
April 17th 2024The use of continuous ofatumumab in patients within three years of a relapsing multiple sclerosis diagnosis led to substantial reductions in associated lesions on brain MRI scans, according to research recently presented at the American Academy of Neurology (AAN) conference.
Could a Deep Learning Model for Mammography Improve Prediction of DCIS and Invasive Breast Cancer?
April 15th 2024Artificial intelligence (AI) assessment of mammography images may significantly enhance the prediction of invasive breast cancer and ductal carcinoma in situ (DCIS) in women with breast cancer, according to new research presented at the Society for Breast Imaging (SBI) conference.
